Live feed16:05:03·2hINSIDERFilingvia QuantisnowChief Executive Officer Ceesay Abraham sold $327,398 worth of shares (8,220 units at $39.83) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 548,027 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.RAPP· Rapport Therapeutics Inc.Health CareOriginal source
